Search Results 181-190 of 6661 for younkin
Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...
This is a Phase 1/2, open-label, dose-escalation, dose-expansion study for the treatment of patients with advanced cancers. Eligible patients with DLBCL or ...
The purpose of this single-dose escalation study is to evaluate the safety and effectiveness of CAR2 Anti-CD38 A2 CAR-T Cells in patients with Relapsed or ...
Jabban Y, He R, Bessonen K, Greipp P, Jevremovic D, Foran J, Yi CA, Saliba AN, Hefazi Torghabeh M, Matin A, Hogan W, Mangaonkar A, Patnaik M, Shah M, ...
About this study. This clinical trial is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The study purpose is to understand patients' with the diagnosis of Diabetes Mellitus type 1 or 2 perception of the care they receive in ...
We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...
Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...
About this study. This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.